TORONTO, ONTARIO--(Marketwire - July 30, 2008) - Primera Bioscience Research Inc. ("Primera Bioscience" or the "Corporation") announces that it has completed the sale of 2,500,000 common shares at $0.10 per share for gross proceeds of $250,000 pursuant to the final prospectus of Primera Bioscience dated July 23, 2008. The common shares of Primera Bioscience do not trade on any stock exchange or market quotation system.
